TABLE OF CONTENTS
1 INTRODUCTION 28
1.1 OBJECTIVES OF THE STUDY 28
1.2 MARKET DEFINITION 28
1.3 OVERVIEW OF MIDDLE EAST & AFRICA MEDICAL DEVICE TESTING MARKET 28
1.4 LIMITATIONS 30
1.5 MARKETS COVERED 30
2 MARKET SEGMENTATION 33
2.1 MARKETS COVERED 33
2.2 GEOGRAPHICAL SCOPE 34
2.3 YEARS CONSIDERED FOR THE STUDY 35
2.4 CURRENCY AND PRICING 35
2.5 DBMR TRIPOD DATA VALIDATION MODEL 36
2.6 MULTIVARIATE MODELLING 39
2.7 SERVICE TYPE LIFELINE CURVE 39
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 40
2.9 DBMR MARKET POSITION GRID 41
2.10 MARKET TESTING TYPE COVERAGE GRID 42
2.11 VENDOR SHARE ANALYSIS 43
2.12 SECONDARY SOURCES 44
2.13 ASSUMPTIONS 44
3 EXECUTIVE SUMMARY 45
4 PREMIUM INSIGHTS 48
4.1 PESTEL ANALYSIS 50
4.2 PORTER'S FIVE FORCES 51
5 MIDDLE EAST & AFRICA MEDICAL DEVICE TESTING MARKET: REGULATIONS 52
6 MARKET OVERVIEW 56
6.1 DRIVERS 58
6.1.1 RISING NEED FOR VERIFICATION VALIDATION OF MEDICAL DEVICES 58
6.1.2 INCREASING DEMAND FOR IN-VITRO TESTS 58
6.1.3 ESCALATION IN INNOVATION AND TECHNOLOGIES 58
6.2 RESTRAINTS 59
6.2.1 BARRIERS TO THE LOCAL DEVELOPMENT OF MEDICAL DEVICES 59
6.2.2 HIGH COST OF MEDICAL DEVICES 59

6.3 OPPORTUNITIES 59
6.3.1 RISE IN HEALTHCARE EXPENDITURE 59
6.3.2 DEVELOPMENT IN AI AND IOT IN VARIOUS MEDICAL DEVICES 60
6.3.3 STRATEGIC INITIATIVES OF KEY PLAYERS 60
6.4 CHALLENGES 61
6.4.1 HIGH COMPETITION IN MEDICAL TECHNOLOGY INDUSTRY 61
6.4.2 LONG LEAD TIME FOR OVERSEAS QUALIFICATION 62
7 MIDDLE EAST & AFRICA MEDICAL DEVICE TESTING MARKET, BY SERVICE TYPE 63
7.1 OVERVIEW 64
7.2 TESTING SERVICES 67
7.3 INSPECTION SERVICES 67
7.4 CERTIFICATION SERVICES 68
8 MIDDLE EAST & AFRICA MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE 70
8.1 OVERVIEW 71
8.2 CHEMICAL/BIOLOGICAL TESTING 74
8.3 MICROBIOLOGY AND STERILITY TESTING 74
8.3.1 STERILITY TEST & VALIDATION 76
8.3.2 BIO BURDEN DETERMINATION 76
8.3.3 ANTIMICROBIAL ACTIVITY TESTING 76
8.3.4 PYROGEN & ENDOTOXIN TESTING 76
8.3.5 OTHERS 76
8.4 PHYSICAL TESTING 76
8.4.1 ELECTRICAL SAFETY TESTING 77
8.4.2 FUNCTIONAL SAFETY TESTING 78
8.4.3 EMC TESTING 78
8.4.4 ENVIRONMENTAL TESTING 78
8.4.5 OTHERS 78
8.5 CYBERSECURITY TESTING 78
8.6 OTHERS 79
9 MIDDLE EAST & AFRICA MEDICAL DEVICE TESTING MARKET, BY PHASE 81
9.1 OVERVIEW 82
9.2 PRECLINICAL 85
9.3 CLINICAL 85
10 MIDDLE EAST & AFRICA MEDICAL DEVICE TESTING MARKET, BY SOURCING TYPE 87
10.1 OVERVIEW 88
10.2 OUTSOURCED 91
10.3 IN-HOUSE 91
11 MIDDLE EAST & AFRICA MEDICAL DEVICE TESTING MARKET, BY DEVICE CLASS 93
11.1 OVERVIEW 94
11.2 CLASS I 97
11.3 CLASS III 98
11.4 CLASS II 98
12 MIDDLE EAST & AFRICA MEDICAL DEVICE TESTING MARKET, BY PRODUCT 100
12.1 OVERVIEW 101
12.2 NON-ACTIVE MEDICAL DEVICE 103
12.3 ORTHOPEDIC AND DENTAL MEDICAL DEVICE 104
12.4 ACTIVE IMPLANT MEDICAL DEVICE 105
12.5 VASCULAR MEDICAL DEVICE 106
12.6 ACTIVE MEDICAL DEVICE 107
12.7 IN-VITRO DIAGNOSTICS MEDICAL DEVICE 107
12.8 OPTHALMIC MEDICAL DEVICE 108
12.9 OTHERS 109
13 MIDDLE EAST & AFRICA MEDICAL DEVICE TESTING MARKET, BY GEOGRAPHY 110
13.1 MIDDLE EAST AND AFRICA 111
13.1.1 SOUTH AFRICA 118
13.1.2 SAUDI ARABIA 121
13.1.3 U.A.E 124
13.1.4 ISRAEL 127
13.1.5 EGYPT 130
13.1.6 REST OF MIDDLE EAST AND AFRICA 133
14 MIDDLE EAST & AFRICA MEDICAL DEVICE TESTING MARKET: COMPANY LANDSCAPE 134
14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 134
15 SWOT ANALYSIS 135
16 COMPANY PROFILE 136
16.1 LABCORP 136
16.1.1 COMPANY SNAPSHOT 136
16.1.2 REVENUE ANALYSIS 136
16.1.3 COMPANY SHARE ANALYSIS 137
16.1.4 PRODUCT PORTFOLIO 137
16.1.5 RECENT DEVELOPMENTS 137

16.2 CHARLES RIVER LABORATORIES. 138
16.2.1 COMPANY SNAPSHOT 138
16.2.2 REVENUE ANALYSIS 138
16.2.3 COMPANY SHARE ANALYSIS 139
16.2.4 PRODUCT PORTFOLIO 139
16.2.5 RECENT DEVELOPMENTS 139
16.3 TUV SUD 140
16.3.1 COMPANY SNAPSHOT 140
16.3.2 REVENUE ANALYSIS 140
16.3.3 COMPANY SHARE ANALYSIS 141
16.3.4 PRODUCT PORTFOLIO 141
16.3.5 RECENT DEVELOPMENTS 142
16.4 WUXI APPTEC 143
16.4.1 COMPANY SNAPSHOT 143
16.4.2 REVENUE ANALYSIS 143
16.4.3 COMPANY SHARE ANALYSIS 144
16.4.4 PRODUCT PORTFOLIO 144
16.4.5 RECENT DEVELOPMENTS 145
16.5 SGS SA 146
16.5.1 COMPANY SNAPSHOT 146
16.5.2 REVENUE ANALYSIS 146
16.5.3 COMPANY SHARE ANALYSIS 147
16.5.4 PRODUCT PORTFOLIO 147
16.5.5 RECENT DEVELOPMENTS 148
16.6 NORTH AMERICAN SCIENCE ASSOCIATES, LLC 149
16.6.1 COMPANY SNAPSHOT 149
16.6.2 PRODUCT PORTFOLIO 149
16.6.3 RECENT DEVELOPMENTS 149
16.7 HOHENSTEIN 150
16.7.1 COMPANY SNAPSHOT 150
16.7.2 PRODUCT PORTFOLIO 150
16.7.3 RECENT DEVELOPMENTS 150
16.8 ARBRO PHARMACEUTICALS PRIVATE LIMITED & AURIGA RESEARCH PRIVATE LIMITED 151
16.8.1 COMPANY SNAPSHOT 151
16.8.2 PRODUCT PORTFOLIO 151
16.8.3 RECENT DEVELOPMENTS 151
16.9 BIOMEDICAL DEVICE LABS 152
16.9.1 COMPANY SNAPSHOT 152
16.9.2 PRODUCT PORTFOLIO 152
16.9.3 RECENT DEVELOPMENTS 152
16.10 BIONEEDS 153
16.10.1 COMPANY SNAPSHOT 153
16.10.2 PRODUCT PORTFOLIO 153
16.10.3 RECENT DEVELOPMENTS 153
16.11 BUREAU VERITAS 154
16.11.1 COMPANY SNAPSHOT 154
16.11.2 REVENUE ANALYSIS 154
16.11.3 PRODUCT PORTFOLIO 155
16.11.4 RECENT DEVELOPMENTS 155
16.12 CIGNITI 156
16.12.1 COMPANY SNAPSHOT 156
16.12.2 REVENUE ANALYSIS 156
16.12.3 PRODUCT PORTFOLIO 157
16.12.4 RECENT DEVELOPMENTS 157
16.13 ELEMENT MATERIALS TECHNOLOGY 158
16.13.1 COMPANY SNAPSHOT 158
16.13.2 PRODUCT PORTFOLIO 158
16.13.3 RECENT DEVELOPMENTS 158
16.14 ENDOLAB MECHANICAL ENGINEERING GMBH 159
16.14.1 COMPANY SNAPSHOT 159
16.14.2 PRODUCT PORTFOLIO 159
16.14.3 RECENT DEVELOPMENTS 159
16.15 EUROFINS SCIENTIFIC 160
16.15.1 COMPANY SNAPSHOT 160
16.15.2 REVENUE ANALYSIS 160
16.15.3 PRODUCT PORTFOLIO 161
16.15.4 RECENT DEVELOPMENTS 161
16.16 GATEWAY ANALYTICAL. 162
16.16.1 COMPANY SNAPSHOT 162
16.16.2 PRODUCT PORTFOLIO 162
16.16.3 RECENT DEVELOPMENTS 162
16.17 IMR TEST LABS 163
16.17.1 COMPANY SNAPSHOT 163
16.17.2 PRODUCT PORTFOLIO 163
16.17.3 RECENT DEVELOPMENTS 163
16.18 INTERTEK GROUP PLC 164
16.18.1 COMPANY SNAPSHOT 164
16.18.2 REVENUE ANALYSIS 164
16.18.3 PRODUCT PORTFOLIO 165
16.18.4 RECENT DEVELOPMENTS 165
16.19 ITC ZLIN 166
16.19.1 COMPANY SNAPSHOT 166
16.19.2 PRODUCT PORTFOLIO 166
16.19.3 RECENT DEVELOPMENTS 166
16.20 MEDICAL ENGINEERING TECHNOLOGIES LTD. 167
16.20.1 COMPANY SNAPSHOT 167
16.20.2 PRODUCT PORTFOLIO 167
16.20.3 RECENT DEVELOPMENTS 167
16.21 MEDISTRI SA 168
16.21.1 COMPANY SNAPSHOT 168
16.21.2 PRODUCT PORTFOLIO 168
16.21.3 RECENT DEVELOPMENTS 168
16.22 NELSON LABORATORIES, LLC- A SOTERA HEALTH COMPANY 169
16.22.1 COMPANY SNAPSHOT 169
16.22.2 REVENUE ANALYSIS 169
16.22.3 PRODUCT PORTFOLIO 170
16.22.4 RECENT DEVELOPMENTS 170
16.23 NSF. 171
16.23.1 COMPANY SNAPSHOT 171
16.23.2 PRODUCT PORTFOLIO 171
16.23.3 RECENT DEVELOPMENTS 171
16.24 PACE 172
16.24.1 COMPANY SNAPSHOT 172
16.24.2 PRODUCT PORTFOLIO 172
16.24.3 RECENT DEVELOPMENTS 172
16.25 Q LABORATORIES 173
16.25.1 COMPANY SNAPSHOT 173
16.25.2 PRODUCT PORTFOLIO 173
16.25.3 RECENT DEVELOPMENTS 173
16.26 TUV RHEINLAND 174
16.26.1 COMPANY SNAPSHOT 174
16.26.2 REVENUE ANALYSIS 174
16.26.3 PRODUCT PORTFOLIO 175
16.26.4 RECENT DEVELOPMENTS 175
16.27 UL LLC 176
16.27.1 COMPANY SNAPSHOT 176
16.27.2 PRODUCT PORTFOLIO 176
16.27.3 RECENT DEVELOPMENTS 177

17 QUESTIONNAIRE 178
18 RELATED REPORTS 181

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.